Merit Medical Systems, Inc. (NASDAQ:MMSI) Q2 2019 Earnings Conference Call Transcript
Jul 25, 2019 • 05:30 pm ET
Good day, ladies and gentleman, and welcome to the MMSI Q2 2019 Earnings Conference Call. [Operator Instructions] As a reminder, this conference call has been recorded for replay purposes.
It is now pleasure to hand the conference over to Mr. Fred Lampropoulos, Chairman and Chief Executive Officer. You may begin.
Good afternoon, ladies and gentleman. This is Fred Lampropoulos, Chairman and CEO, and we're broadcasting this afternoon from very warm Salt Lake City, Utah. Thank you for taking the time to join us. We've I think a lot of very , very important information to share with you. But before doing that, I'd like to turn the time over to Brian Lloyd, our General Counsel to read our Safe Harbor provision. Brian?
Brian G. Lloyd
Thank you, Fred. During our discussion today, reference may be made to projections, anticipated events or other information, which is not purely historical. Please be aware that statements made in this call, which are not purely historical may be considered forward-looking statements. We caution you that all forward-looking statements involve risks, unanticipated events and uncertainties that could cause our actual results to differ materially from those anticipated in such statements. Many of these risks are discussed in our annual report on Form 10-K and other reports and filings with the Securities and Exchange Commission and are available on our website.
Some of these risks are identified in our press release and slide presentation distributed in connection with this call. Any forward-looking statements made in this call are made only as of today's date, and except as required by law or regulation, we do not assume any obligation to update any such statements whether as a result of new information, future events or otherwise. Please refer to the section of our presentation entitled disclosure regarding forward-looking statements for important information regarding such statements. Our financial statements are prepared in accordance with accounting principles which are generally accepted in the United States.
However, we believe certain non-GAAP financial measures provide investors with useful information regarding the underlying business trends and performance of our ongoing operations and can be useful for period-over-period comparisons of such operations. The tables included in our release and discussed on this call set forth supplemental financial data and corresponding reconciliations to GAAP financial statements. Please refer to the sections of our presentation entitled non-GAAP financial measures and notes to non-GAAP financial measures for important information regarding non-GAAP financial measures discussed on this call. Readers should consider non-GAAP measures in addition to, not as a substitute for, financial reporting measures prepared in accordance with GAAP. These non-GAAP financial measures exclude some items that affect net income.
Finally, these calculations may not be comparable with similarly titled measures of other companies.
Brian, thank you very much. Ladies and gentlemen, again, thank you for joining us. Well, I think as you can see, the second quarter was somewhat difficult for us. I want to make sure that everybody understands upfront that this has not dampened our enthusiasm for the business,